Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-15-007932
Filing Date
2015-04-23
Accepted
2015-04-23 13:05:53
Documents
1
Period of Report
2015-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5429
  Complete submission text file 0001437749-15-007932.txt   7071
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Issuer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address TWO BALA PLAZA, SUITE 300 PHILADELPHIA PA 19004
Business Address
Reynolds Mark (Reporting) CIK: 0001298237 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52091 | Film No.: 15787808